GSK’s drug to fight urinary tract infections gets USFDA approval
HQ Team March 26, 2025: The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team March 26, 2025: The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in.
HQ Times January 2, 2025: Women tend to binge drink when their estrogen levels are high, according to a research conducted by scientists.
Kezar Life Sciences Inc., a US-based biotechnology company, has stopped a trial in patients with a type of kidney disease after four people.
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
HQ Team February 20, 2024: About 16% of children or one in six children under two years of age in the Northern Gaza.
Bharti Jayshankar February 2, 2024: A new study has come up with an explanation for the heightened susceptibility of women to autoimmune diseases.
Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.